SCHEMBL19082190

SCHEMBL19082190

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cc5sc6ccccc6c5c5c4sc4c6ccccc6ccc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.40
CYP1B1 Q16678 6/20 0.40
F9 P00740 1/20 0.37
CHEK1 O14757 1/20 0.34
WEE1 P30291 1/20 0.34
CYP1A2 P05177 5/20 0.34
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
PTPN1 P18031 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
SOS1 Q07889 1/20 0.32
ALDH1A1 P00352 3/20 0.30
HPGD P15428 3/20 0.30
MAPT P10636 2/20 0.30
GPR3 P46089 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945695 0.89 PTPN1 (0.39) F9CHEK1WEE1PTPN1MEN1
SCHEMBL19082206 0.87 CYP1A1 (0.38) CYP1A1CYP1B1F9CHEK1WEE1
SCHEMBL19082274 0.86 CYP1A1 (0.36) CYP1A1CYP1B1F9CYP1A2NQO1
SCHEMBL19082142 0.86 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082349 0.84 CYP1A1 (0.39) CYP1A1CYP1B1F9CHEK1WEE1
SCHEMBL24614929 0.83 PTPN1 (0.36) F9CHEK1WEE1NQO1NQO2
SCHEMBL19082327 0.82 CYP1A1 (0.41) CYP1A1CYP1B1F9CHEK1WEE1
SCHEMBL19082387 0.82 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082182 0.81 CYP1A1 (0.40) CYP1A1CYP1B1F9CHEK1WEE1
SCHEMBL17945467 0.81 ALOX5 (0.37) NQO1NQO2PTPN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.